[1] Saier MH, Daniels GA, Boemer P, et al. amino acid transport systems in animal cells:Potential targets of oncogene action and regulators of cellular growth[J]. J Membr Biol, 1988, 104:1-20.
[2] Souba WW, Pacitti AJ. How amino acids get into cells:machnisms, models, menusand mediators[J]. J Parenter Enteral Nutr, 1992, 16:569-578.
[3] Jager PL, Vaalburg W, Pruim J, et al. Radiolabeled amino acids:Basic aspects and clinical application in oncology[J]. J Nucl Med, 2001, 42:432-445.
[4] Langstrom B, Antoni G, Gullberg P, et al. Synthesis of Land D-[methyl-11C] methionine[J]. J Nucl Med, 1987, 28:1037-1040.
[5] Kubota K, Ishiwata K, Kubota R, et al. Tracer feasibility for monitoring tumor radiotherapy, a quadruple tracer study with flulrine-18-fluorodoexyglucose or fluorine-18-fluo-rodeoxyuridine, L-[methyl-11C-] methionine,[6-3H] thymidine,and gallium-67[J]. J Nucl Med,1991,32:2118-2123.
[6] Daemen BJG, Elsinga PH, Paans AMJ, et al. Radiation-induced inhibition of tumor growth as monitored by PET using L-[1-11C] tyrosine and fluorine-18-fluorodeoxyglucose[J]. J Nucl Med, 1992, 22:373-379.
[7] Langen KJ, Muhlensiepen H, Holschbach M, et al. Transport mechanisms of I-123 iodo-alphamethyl-L-Ltyro-sine in a human glioma cell line:comparison with [methyl-3H]-L-methionine[J]. J Nucl Med, 2000, 41:1250-1255.
[8] Jager PL, Franssen EJ, Kool W, et al. Feasibility of tumor imaging using L-3-[iodine-123] -iodo-alpha-methyl-tyrosine in extracranial tumors[J]. J Nucl Med, 1998, 39:1736-1743.
[9] Jager PL, Plaat BE, Vriesde EG, et al. Imaging of soft-tis-sue tumors using L-3-[iodine-123] iodo-alpha-methyl-tyro-sine SPECT:comparison with proliferative and mitotic activity, cellularity and vascularity[J]. Clin Cancer Res, 2000, 6:2252-2259.